Latest Partnerships News

Eclipse Metals Ltd reported significant progress in its March 2025 quarter, highlighting new high-grade rare earth mineralisation in Greenland and a strategic uranium project earn-in agreement in Australia.

4DS Memory Limited has successfully manufactured its first 20nm memory cell array, marking a pivotal step in its ReRAM technology development, while raising $8.6 million through a placement and Share Purchase Plan to fuel ongoing innovation.

Emmerson Resources has significantly expanded its White Devil gold resource by 25% to over 611,000 ounces, driving a 162% increase in the total Tennant Creek resource base. Meanwhile, commissioning of the Nobles CIL processing plant is ahead of schedule, setting the stage for imminent gold production.

Norfolk Metals has secured a binding earn-in agreement to acquire a majority stake in the Carmen Copper Project in Chile, backed by a $1 million capital raising commitment. The company is progressing exploration plans alongside ongoing work at its uranium and gold-copper projects.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

Cassius Mining Limited reports significant progress on its Soalara Limestone Project in Madagascar, alongside ongoing international arbitration against Ghana seeking USD 277 million in damages. The company also strengthens its balance sheet with recent equity raises totaling approximately AUD 1.53 million.

Kinetiko Energy reports encouraging progress in South African gas exploration, with improved well performance and a drilling optimisation study revealing key production enhancements.

Australian Rare Earths Limited (ASX: AR3) has secured a $5 million government grant to advance its Koppamurra Rare Earths Project, confirmed promising uranium mineralisation at its Overland Project, and raised $3.6 million through a rights issue to accelerate development.

Lakes Blue Energy is progressing regulatory approvals and has locked in a drilling rig for its Wombat-5 gas well, while reporting a $1.48 million operating cash outflow and maintaining $3.55 million in cash at quarter-end.

Dimerix Limited advances its Phase 3 kidney disease trial with FDA acceptance of proteinuria as a primary endpoint and clinches a lucrative licensing agreement in Japan worth up to AU$107 million plus royalties.

X2M Connect reports a challenging quarter with a 64% revenue drop due to exiting low-margin hardware sales but boosts gross margin and expands its footprint with new contracts in the Middle East and South Korea alongside launching an AI platform for renewables.

Evion Group has marked a key milestone with its first expandable graphite shipment from its India joint venture, while progressing critical permitting for its flagship Maniry Graphite Project in Madagascar. The company also secured $2 million in funding to support expansion and development.